| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 4 | 0.741 | Human |
| fat cell differentiation | GO:0045444 | 160 | 0.627 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.574 | |
| negative regulation of protein kinase activity by regulation of protein phosphorylation | GO:0044387 | 2 | 0.548 | |
| cellular response to calcium ion | GO:0071277 | 14 | 0.541 | |
| regulation of ovulation | GO:0060278 | 3 | 0.527 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.507 | Human |
| gene silencing by mirna | GO:0035195 | 10 | 0.472 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.461 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.461 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.456 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.444 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.431 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.417 | |
| regulation of cyclin dependent protein serine threonine kinase activity involved in g2 m transition of mitotic cell cycle | GO:0031660 | 1 | 0.405 | |
| response to oxidative stress | GO:0006979 | 123 | 0.395 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.376 | |
| negative regulation of respiratory burst involved in inflammatory response | GO:0060266 | 1 | 0.375 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.371 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.364 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.357 | |
| axonogenesis | GO:0007409 | 274 | 0.335 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.320 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.317 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.313 | |
| vitellogenesis | GO:0007296 | 2 | 0.308 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.306 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.304 | |
| positive regulation of transcription from rna polymerase i promoter | GO:0045943 | 3 | 0.300 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.283 | |
| amine metabolic process | GO:0009308 | 45 | 0.276 | |
| negative regulation of transcription from rna polymerase ii promoter in response to stress | GO:0097201 | 1 | 0.275 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.265 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.263 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.261 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.260 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.258 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.258 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.254 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.251 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.237 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.231 | |
| gliogenesis | GO:0042063 | 141 | 0.228 | |
| placenta development | GO:0001890 | 140 | 0.227 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.216 | |
| microglial cell activation | GO:0001774 | 3 | 0.211 | |
| muscle tissue development | GO:0060537 | 308 | 0.210 | |
| regulation of respiratory burst involved in inflammatory response | GO:0060264 | 2 | 0.209 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.209 | |
| liver development | GO:0001889 | 66 | 0.208 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.206 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.205 | Human |
| regulation of kinase activity | GO:0043549 | 249 | 0.204 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.204 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.202 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.200 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.198 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.194 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.192 | Human |
| osteoclast differentiation | GO:0030316 | 62 | 0.183 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.181 | Human |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.179 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.176 | Human |
| regulation of respiratory burst | GO:0060263 | 2 | 0.176 | |
| adrenal cortex formation | GO:0035802 | 2 | 0.173 | |
| positive regulation of mrna catabolic process | GO:0061014 | 5 | 0.172 | Human |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.172 | Human |
| positive regulation of osteoclast differentiation | GO:0045672 | 15 | 0.171 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.166 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.160 | |
| regulation of brown fat cell differentiation | GO:0090335 | 5 | 0.158 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.155 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.155 | |
| positive regulation of mrna 3 end processing | GO:0031442 | 5 | 0.154 | Human |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.151 | |
| rna processing | GO:0006396 | 105 | 0.149 | Human |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.147 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.147 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.146 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.145 | |
| digestive tract development | GO:0048565 | 190 | 0.143 | |
| chromatin organization | GO:0006325 | 206 | 0.143 | |
| rna 3 end processing | GO:0031123 | 20 | 0.143 | Human |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.142 | |
| blastocyst development | GO:0001824 | 80 | 0.141 | |
| embryonic placenta development | GO:0001892 | 98 | 0.139 | |
| jnk cascade | GO:0007254 | 72 | 0.139 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.138 | |
| cardiac muscle hypertrophy in response to stress | GO:0014898 | 10 | 0.138 | |
| carbohydrate transport | GO:0008643 | 62 | 0.133 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.132 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.132 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.130 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.128 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.126 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.123 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.122 | |
| muscle system process | GO:0003012 | 141 | 0.121 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.120 | |
| response to inorganic substance | GO:0010035 | 96 | 0.119 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.119 | |
| mapk cascade | GO:0000165 | 281 | 0.117 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.117 | |
| developmental maturation | GO:0021700 | 193 | 0.116 | |
| t cell activation | GO:0042110 | 289 | 0.115 | |
| cell maturation | GO:0048469 | 127 | 0.115 | |
| cytokine production | GO:0001816 | 319 | 0.114 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.114 | |
| cellular response to peptide | GO:1901653 | 92 | 0.114 | |
| axon regeneration | GO:0031103 | 12 | 0.113 | |
| glomerular visceral epithelial cell differentiation | GO:0072112 | 10 | 0.112 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.111 | Human |
| neuron death | GO:0070997 | 154 | 0.110 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.109 | |
| response to growth factor | GO:0070848 | 198 | 0.109 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.108 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.107 | |
| embryonic process involved in female pregnancy | GO:0060136 | 7 | 0.105 | |
| renal system development | GO:0072001 | 225 | 0.105 | |
| renal filtration cell differentiation | GO:0061318 | 10 | 0.105 | |
| skin development | GO:0043588 | 220 | 0.105 | |
| locomotory behavior | GO:0007626 | 195 | 0.104 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.101 | |
| glial cell differentiation | GO:0010001 | 131 | 0.099 | |
| urogenital system development | GO:0001655 | 261 | 0.099 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.099 | |
| central nervous system segmentation | GO:0035283 | 3 | 0.097 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.095 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.095 | |
| chromatin modification | GO:0016568 | 187 | 0.095 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.094 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.094 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.092 | Human |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.092 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.091 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.091 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.090 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.090 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.089 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.089 | |
| mrna catabolic process | GO:0006402 | 22 | 0.089 | Human |
| positive regulation of fibroblast proliferation | GO:0048146 | 20 | 0.088 | |
| regulation of neuron death | GO:1901214 | 134 | 0.088 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.087 | |
| ossification | GO:0001503 | 216 | 0.087 | |
| multicellular organism growth | GO:0035264 | 161 | 0.086 | |
| camera type eye development | GO:0043010 | 266 | 0.086 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.085 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.083 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.082 | |
| response to nutrient levels | GO:0031667 | 109 | 0.082 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.081 | |
| nerve development | GO:0021675 | 67 | 0.081 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.081 | |
| adaptive immune response | GO:0002250 | 155 | 0.081 | |
| negative regulation of ovulation | GO:0060280 | 1 | 0.080 | |
| negative regulation of stem cell differentiation | GO:2000737 | 14 | 0.079 | |
| regulation of ossification | GO:0030278 | 112 | 0.079 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.079 | Human |
| dendrite development | GO:0016358 | 115 | 0.079 | |
| neural tube development | GO:0021915 | 160 | 0.078 | |
| gland development | GO:0048732 | 330 | 0.078 | |
| general adaptation syndrome | GO:0051866 | 2 | 0.078 | |
| hexose transport | GO:0008645 | 56 | 0.077 | |
| rna interference | GO:0016246 | 2 | 0.077 | |
| compound eye development | GO:0048749 | 1 | 0.076 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.076 | |
| response to metal ion | GO:0010038 | 47 | 0.074 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.074 | Human |
| response to calcium ion | GO:0051592 | 20 | 0.074 | |
| vestibular reflex | GO:0060005 | 4 | 0.074 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.074 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.074 | Human |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.073 | |
| neuron projection regeneration | GO:0031102 | 14 | 0.073 | |
| dephosphorylation | GO:0016311 | 129 | 0.072 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.072 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.072 | |
| post embryonic camera type eye development | GO:0031077 | 8 | 0.072 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.072 | |
| stem cell differentiation | GO:0048863 | 268 | 0.071 | |
| stem cell development | GO:0048864 | 219 | 0.070 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.070 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.069 | |
| kidney development | GO:0001822 | 213 | 0.068 | |
| regulation of translation | GO:0006417 | 71 | 0.068 | Human |
| mrna processing | GO:0006397 | 63 | 0.067 | Human |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.067 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.067 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.067 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.067 | |
| epithelial cell development | GO:0002064 | 159 | 0.067 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.066 | |
| positive regulation of protein deacetylation | GO:0090312 | 9 | 0.066 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.065 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.065 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.065 | |
| axon guidance | GO:0007411 | 141 | 0.064 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.064 | |
| sperm motility | GO:0030317 | 47 | 0.064 | |
| respiratory system development | GO:0060541 | 190 | 0.064 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.064 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.064 | |
| cell adhesion | GO:0007155 | 329 | 0.064 | |
| epidermis development | GO:0008544 | 187 | 0.063 | |
| glomerulus development | GO:0032835 | 40 | 0.063 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.062 | |
| macrophage activation | GO:0042116 | 27 | 0.062 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.062 | |
| erythrocyte maturation | GO:0043249 | 6 | 0.062 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.062 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.062 | |
| regulation of histone modification | GO:0031056 | 56 | 0.061 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.061 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.060 | |
| nephron development | GO:0072006 | 109 | 0.060 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.060 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.059 | |
| nephron epithelium development | GO:0072009 | 92 | 0.059 | |
| wound healing | GO:0042060 | 157 | 0.059 | |
| interleukin 8 production | GO:0032637 | 4 | 0.059 | |
| stem cell maintenance | GO:0019827 | 130 | 0.058 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.058 | |
| regulation of mrna 3 end processing | GO:0031440 | 6 | 0.058 | Human |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.058 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.058 | |
| adrenal cortex development | GO:0035801 | 2 | 0.058 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.057 | |
| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 1 | 0.057 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.057 | |
| 3 utr mediated mrna stabilization | GO:0070935 | 2 | 0.056 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.056 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.056 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.056 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.055 | |
| blastocyst formation | GO:0001825 | 33 | 0.055 | |
| endocytosis | GO:0006897 | 168 | 0.055 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.055 | |
| telencephalon development | GO:0021537 | 186 | 0.054 | |
| digestive system development | GO:0055123 | 200 | 0.054 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.054 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.054 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.053 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.053 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.053 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.053 | |
| response to acid chemical | GO:0001101 | 111 | 0.053 | |
| regulation of dopamine metabolic process | GO:0042053 | 10 | 0.052 | |
| glomerular epithelial cell differentiation | GO:0072311 | 10 | 0.052 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.052 | |
| facial nerve morphogenesis | GO:0021610 | 11 | 0.052 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.052 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.052 | |
| associative learning | GO:0008306 | 61 | 0.052 | |
| immune effector process | GO:0002252 | 321 | 0.051 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.051 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.051 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.051 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.051 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.051 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.051 | Human |
| kidney epithelium development | GO:0072073 | 121 | 0.051 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.050 | |
| regulation of heart growth | GO:0060420 | 31 | 0.050 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.050 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.050 | |
| cellular response to antibiotic | GO:0071236 | 4 | 0.050 | |
| regulation of protein autophosphorylation | GO:0031952 | 8 | 0.050 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.049 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.049 | |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061179 | 4 | 0.048 | |
| monosaccharide transport | GO:0015749 | 58 | 0.048 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.048 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.048 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.048 | |
| rhombomere formation | GO:0021594 | 1 | 0.048 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.047 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.047 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.047 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.047 | |
| synapse organization | GO:0050808 | 125 | 0.047 | |
| rhombomere 5 morphogenesis | GO:0021664 | 1 | 0.047 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.047 | |
| regionalization | GO:0003002 | 337 | 0.047 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.046 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.046 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.046 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.046 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.046 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.045 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.045 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.045 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.045 | |
| chorio allantoic fusion | GO:0060710 | 8 | 0.045 | |
| histone deacetylation | GO:0016575 | 26 | 0.045 | |
| muscle adaptation | GO:0043500 | 39 | 0.044 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.044 | Human |
| protein acylation | GO:0043543 | 64 | 0.044 | |
| circulatory system process | GO:0003013 | 197 | 0.044 | |
| glucose metabolic process | GO:0006006 | 92 | 0.044 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.044 | |
| monocyte differentiation | GO:0030224 | 9 | 0.044 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.043 | |
| central nervous system projection neuron axonogenesis | GO:0021952 | 21 | 0.043 | |
| lung cell differentiation | GO:0060479 | 30 | 0.043 | |
| negative regulation of metanephric glomerulus development | GO:0072299 | 1 | 0.043 | |
| response to amphetamine | GO:0001975 | 16 | 0.043 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.043 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.042 | |
| blood circulation | GO:0008015 | 195 | 0.042 | |
| respiratory burst | GO:0045730 | 8 | 0.042 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.042 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.042 | |
| inflammatory response | GO:0006954 | 244 | 0.041 | |
| t cell differentiation | GO:0030217 | 174 | 0.041 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.041 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.041 | |
| response to radiation | GO:0009314 | 165 | 0.041 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.041 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.041 | |
| response to light stimulus | GO:0009416 | 135 | 0.041 | |
| intestinal epithelial cell development | GO:0060576 | 12 | 0.041 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.040 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.040 | |
| viral transcription | GO:0019083 | 3 | 0.040 | |
| circadian behavior | GO:0048512 | 13 | 0.040 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.040 | |
| gene silencing | GO:0016458 | 38 | 0.040 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.039 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.039 | |
| respiratory burst involved in defense response | GO:0002679 | 6 | 0.039 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.039 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.039 | |
| cell division | GO:0051301 | 120 | 0.039 | |
| positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900153 | 5 | 0.039 | Human |
| fertilization | GO:0009566 | 127 | 0.039 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.038 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.038 | |
| response to drug | GO:0042493 | 75 | 0.038 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.038 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.038 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.037 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.037 | |
| regulation of cell motility | GO:2000145 | 236 | 0.037 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.037 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.037 | |
| production of molecular mediator involved in inflammatory response | GO:0002532 | 21 | 0.036 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.036 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.036 | |
| angiogenesis | GO:0001525 | 201 | 0.036 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.036 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.036 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.036 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.036 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.036 | |
| osteoblast proliferation | GO:0033687 | 18 | 0.036 | |
| rhythmic process | GO:0048511 | 174 | 0.036 | |
| epithalamus development | GO:0021538 | 2 | 0.035 | |
| histone modification | GO:0016570 | 159 | 0.035 | |
| lateral inhibition | GO:0046331 | 1 | 0.035 | |
| brain segmentation | GO:0035284 | 3 | 0.035 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.035 | |
| cranial nerve morphogenesis | GO:0021602 | 26 | 0.035 | |
| male gamete generation | GO:0048232 | 285 | 0.035 | |
| ear development | GO:0043583 | 200 | 0.035 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.034 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.034 | |
| gastrulation | GO:0007369 | 116 | 0.034 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.034 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.033 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.033 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.033 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.033 | |
| labyrinthine layer morphogenesis | GO:0060713 | 21 | 0.033 | |
| single organism nuclear import | GO:1902593 | 95 | 0.033 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.033 | |
| mesoderm development | GO:0007498 | 100 | 0.033 | |
| chemotaxis | GO:0006935 | 247 | 0.033 | |
| proepicardium development | GO:0003342 | 2 | 0.033 | |
| negative regulation of response to biotic stimulus | GO:0002832 | 10 | 0.033 | |
| viral gene expression | GO:0019080 | 3 | 0.033 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.033 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.033 | |
| regulation of mrna catabolic process | GO:0061013 | 6 | 0.032 | Human |
| rhombomere 5 formation | GO:0021666 | 1 | 0.032 | |
| organelle assembly | GO:0070925 | 177 | 0.032 | |
| negative regulation of respiratory burst | GO:0060268 | 1 | 0.032 | |
| lung development | GO:0030324 | 164 | 0.032 | |
| learning | GO:0007612 | 98 | 0.032 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.032 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.032 | |
| regeneration | GO:0031099 | 38 | 0.032 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.032 | |
| negative regulation of translation | GO:0017148 | 22 | 0.032 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.032 | |
| negative regulation of metanephric glomerular mesangial cell proliferation | GO:0072302 | 1 | 0.032 | |
| actin filament organization | GO:0007015 | 113 | 0.031 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.031 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.031 | Human |
| cell fate commitment | GO:0045165 | 210 | 0.031 | |
| positive regulation of rhodopsin gene expression | GO:0045872 | 2 | 0.031 | |
| neuron maturation | GO:0042551 | 29 | 0.031 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.031 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.031 | |
| female gamete generation | GO:0007292 | 74 | 0.031 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.031 | |
| heart growth | GO:0060419 | 45 | 0.031 | |
| response to oxygen levels | GO:0070482 | 62 | 0.031 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.031 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.030 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.030 | |
| muscle hypertrophy in response to stress | GO:0003299 | 10 | 0.030 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.030 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.030 | |
| response to catecholamine | GO:0071869 | 4 | 0.030 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.030 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.030 | |
| regulation of protein sumoylation | GO:0033233 | 4 | 0.030 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.030 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.030 | |
| response to corticosterone | GO:0051412 | 1 | 0.029 | |
| maintenance of location | GO:0051235 | 89 | 0.029 | |
| segmentation | GO:0035282 | 93 | 0.029 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.029 | |
| regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900211 | 4 | 0.029 | |
| cranial nerve development | GO:0021545 | 41 | 0.029 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.029 | |
| mrna destabilization | GO:0061157 | 4 | 0.029 | |
| hexose metabolic process | GO:0019318 | 98 | 0.029 | |
| synapse assembly | GO:0007416 | 56 | 0.029 | |
| intracellular protein transport | GO:0006886 | 204 | 0.029 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.029 | |
| negative regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900212 | 4 | 0.028 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.028 | |
| heart contraction | GO:0060047 | 93 | 0.028 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.028 | Human |
| regulation of jun kinase activity | GO:0043506 | 40 | 0.028 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.028 | |
| phagocytosis | GO:0006909 | 66 | 0.028 | |
| nuclear transport | GO:0051169 | 139 | 0.028 | |
| activation of mapkkk activity | GO:0000185 | 1 | 0.027 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.027 | |
| response to steroid hormone | GO:0048545 | 56 | 0.027 | |
| sensory system development | GO:0048880 | 3 | 0.027 | |
| positive regulation of mrna processing | GO:0050685 | 16 | 0.027 | Human |
| type i pneumocyte differentiation | GO:0060509 | 7 | 0.027 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.027 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.027 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.026 | |
| adult behavior | GO:0030534 | 135 | 0.026 | |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.026 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.026 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.026 | |
| cellular response to fluid shear stress | GO:0071498 | 4 | 0.026 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.026 | |
| cation transport | GO:0006812 | 399 | 0.026 | |
| response to purine containing compound | GO:0014074 | 28 | 0.026 | |
| regulation of metanephric glomerular mesangial cell proliferation | GO:0072301 | 1 | 0.026 | |
| adipose tissue development | GO:0060612 | 25 | 0.026 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.026 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.026 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.026 | |
| cranial nerve formation | GO:0021603 | 4 | 0.026 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.026 | |
| hindbrain development | GO:0030902 | 128 | 0.026 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.026 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.025 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.025 | |
| synaptic transmission | GO:0007268 | 329 | 0.025 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.025 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.025 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.025 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.025 | |
| nuclear division | GO:0000280 | 158 | 0.025 | |
| negative regulation of chemokine production | GO:0032682 | 4 | 0.025 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.025 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.025 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.025 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.024 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.024 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.024 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.024 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.024 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.024 | |
| embryonic placenta morphogenesis | GO:0060669 | 25 | 0.024 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.024 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.024 | |
| gene silencing by rna | GO:0031047 | 19 | 0.024 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.024 | |
| response to hypoxia | GO:0001666 | 58 | 0.024 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.024 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.023 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.023 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 22 | 0.023 | |
